Cardio Catch-Up: Updates From B-Secur, egnite, Vektor, And Other Under-The-Radar Companies
Executive Summary
This edition of Medtech Insight’s Cardiovascular Catch-Up features highlights from recent interviews with leaders of some not-so-famous companies addressing cardiovascular health from a variety of angles – from improving the traditional stethoscope to non-invasive 3D mapping of arrhythmias and more.
You may also be interested in...
Philips Asks Health Care Leaders: How Ready Are You For The Global Health Care Challenge?
Every year since 2016, Royal Philips has polled health care leaders for their views on trends in the market, providing useful information for the wider medtech industry as it shapes its response to evolving needs. The Future Health Index 2022 shows that industry is finally looking beyond COVID-19.
Cardiovascular Catch-Up: Abbott Launches Trial Of Dual-Chamber Leadless Pacer; Cardialen Studies Low-Energy Arrhythmia Treatment; And More
Medtech Insight’s Cardiovascular Catch-Up highlights recent news and insights from cardiovascular device companies – big and small – that you might have missed.
Minute Insight: Acutus Adds Another Device To The Left-Heart Business It Sold To Medtronic
The company announced the US launch of the AcQCross Qx transseptal dilator/needle. It is specifically designed to help deploy Boston Scientific’s Watchman left-atrial appendage closure device, but it is part of the left-heart access device portfolio that Acutus recently sold to Medtronic.